A.T Joonyar Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Months 25 Days
About A.T Joonyar Pharmaceuticals
A.T Joonyar Pharmaceuticals Private Limited (AJPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 June 2024 ( seven months 25 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Gokani, Urun Gokani, Milan Dadhania, and One other member serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U47721GJ2024PTC152292
-
Company No.
152292
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Jun 2024
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Who are the key members and board of directors at A.T Joonyar Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Gokani
|
Director | 07-Jun-2024 | Current |
|
Urun Gokani
|
Director | 07-Jun-2024 | Current |
|
Milan Dadhania
|
Director | 07-Jun-2024 | Current |
|
Rajesh Adeshra
|
Director | 07-Jun-2024 | Current |
Financial Performance of A.T Joonyar Pharmaceuticals.
Enhance accessibility to A.T Joonyar Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of A.T Joonyar Pharmaceuticals?
Unlock access to A.T Joonyar Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Royal Bharti Infracorp Private LimitedRajesh Adeshra is a mutual person
-
Royal Bharti Infraventures Private LimitedRajesh Adeshra is a mutual person
-
Prasvegas Infraventures Private Limited
Rajesh Adeshra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at A.T Joonyar Pharmaceuticals?
Unlock and access historical data on people associated with A.T Joonyar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A.T Joonyar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A.T Joonyar Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.